Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1
about
A large scale shRNA barcode screen identifies the circadian clock component ARNTL as putative regulator of the p53 tumor suppressor pathwayA bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory responseABIN-2 forms a ternary complex with TPL-2 and NF-kappa B1 p105 and is essential for TPL-2 protein stabilityOptineurin negatively regulates the induction of IFNbeta in response to RNA virus infectionUbiquitin binding mediates the NF-kappaB inhibitory potential of ABIN proteinsLIND/ABIN-3 is a novel lipopolysaccharide-inducible inhibitor of NF-kappaB activationA large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosusABIN-1 is a ubiquitin sensor that restricts cell death and sustains embryonic developmentThe TLR and IL-1 signalling network at a glanceA20-Binding Inhibitor of NF-κB Activation 1 is a Physiologic Inhibitor of NF-κB: A Molecular Switch for Inflammation and AutoimmunityLinear ubiquitination signals in adaptive immune responsesIdentification of Naf1/ABIN-1 among TNF-alpha-induced expressed genes in human synoviocytes using oligonucleotide microarraysRegulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinaseABIN-2 is required for optimal activation of Erk MAP kinase in innate immune responsesConstruction of a fusion protein expression vector MK-EGFP and its subcellular localization in different carcinoma cell lines.Induction of a chemoattractant transcriptional response by a Campylobacter jejuni boiled cell extract in colonocytes.Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatasesNaringenin attenuates mucous hypersecretion by modulating reactive oxygen species production and inhibiting NF-κB activity via EGFR-PI3K-Akt/ERK MAPKinase signaling in human airway epithelial cells.TNIP1 is a corepressor of agonist-bound PPARs.TNIP1 reduction of HSPA6 gene expression occurs in promoter regions lacking binding sites for known TNIP1-repressed transcription factorsPolyubiquitin binding to ABIN1 is required to prevent autoimmunity.PPARγ and NF-κB regulate the gene promoter activity of their shared repressor, TNIP1Downregulation of TNIP1 Expression Leads to Increased Proliferation of Human Keratinocytes and Severer Psoriasis-Like Conditions in an Imiquimod-Induced Mouse Model of DermatitisTNIP1, a retinoic acid receptor corepressor and A20-binding inhibitor of NF-κB, distributes to both nuclear and cytoplasmic locationsABIN-3: a molecular basis for species divergence in interleukin-10-induced anti-inflammatory actionsEmerging roles for TNIP1 in regulating post-receptor signalingA comprehensive map of the toll-like receptor signaling network.Human TNFα-induced protein 3-interacting protein 1 (TNIP1) promoter activation is regulated by retinoic acid receptorsTGF-β induces miR-182 to sustain NF-κB activation in glioma subsets.HIV-1 Nef-associated Factor 1 Enhances Viral Production by Interacting with CRM1 to Promote Nuclear Export of Unspliced HIV-1 gag mRNA.Genetic susceptibility to lupus: the biological basis of genetic risk found in B cell signaling pathways.Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomesABIN1 dysfunction as a genetic basis for lupus nephritis.A20: central gatekeeper in inflammation and immunity.Liganded RARalpha and RARgamma interact with but are repressed by TNIP1.Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.Deubiquitinases in the regulation of NF-κB signaling.Regulation of NF-κB signaling by the A20 deubiquitinase.Regulation of NF-κB by deubiquitinases.Molecular control of the NEMO family of ubiquitin-binding proteins.
P2860
Q21562478-213D80F5-2B27-4E5F-A524-9C26BED7A10CQ22001534-401FAD3D-868D-4E7E-867C-C56C05BBF40BQ24294653-DCECFF04-64DF-4831-85EA-D6EC1529A618Q24300481-9C8EF968-BA43-4BBA-B9D7-9A011636F576Q24307510-BB002266-F456-4D64-AA6E-94B37786DB09Q24312754-E4A3334E-C250-4D14-A3C7-DBB079DB53BBQ24629130-0F9D2EFC-4BD9-4BA6-BED0-DB137CF20327Q24653526-B1893BFF-6AB2-4B89-A4BD-FEC103D5857DQ27013358-CADBAF0F-1C06-45C1-8BC9-D4C80713F6B3Q27021657-0255384E-65A9-41B6-8C70-A5C6199FCDACQ27027872-BB236856-ADF3-4FB9-A855-9665E8D14CA1Q28205951-51F1F650-A8E9-420A-A240-3031C9D194A7Q28392677-B3B572A2-5C60-4A3D-8E69-A69B26C2367EQ28585458-6C811B2E-975B-4940-B843-83409C60A425Q33266700-953A2B63-4F45-4006-8A69-60B9425E2B90Q33405651-B9E27A5A-96D4-4D08-946F-C6C204342657Q33636430-1D8137B8-C71B-459E-9835-094C5420F81AQ33791972-1FAAACA0-CAA8-4AE0-A7A7-684CE5D212E7Q34038903-91C3985E-F952-4256-8469-36E37F631B7AQ34714229-A8500550-E113-4911-8F4E-76072A2112C8Q35213554-85E6C0F9-278C-4252-A1CB-CA6E7619680EQ35645219-5F10E289-49E6-4984-9F7E-FA3022ECCA02Q35653856-4A6904B1-5395-4291-B69B-0079CF120976Q35767929-AB14B907-18AA-46CF-8EDF-F59226D62C73Q35948145-8B8960A1-E74C-44D9-B8DD-27F7EB135278Q36003961-9D721E4B-22A4-4E6F-824B-14886E5D1DB9Q36494115-D7CFA764-E8AF-46EE-B75E-6D1D936F4A45Q36532697-8E320489-DABD-4CE5-8D4A-3A3A87A7346DQ36659217-4190CEF9-21D8-4F46-A160-80DB030B591CQ36744542-26BB04A7-ACCA-4B9F-BA2C-0A2C975FBFFEQ37107525-B440A783-C7D5-4559-B420-B20ED79930D8Q37141177-16F3D3FF-2E1B-454F-8A4A-BB39A9888FDCQ37260222-9B42970B-56BB-43E1-B453-52A58DF59006Q37325315-C6BB0D1A-B5EF-4489-B1F1-35726D3A5818Q37382250-C8190877-B280-47B8-83A0-7681F8A13BF1Q37512889-A544BEF3-B5C2-4002-B7B8-2D689AACE017Q37814068-40D2006F-BE56-41BF-82AA-D45920F7FB6BQ37985541-7151AD10-AE21-4E81-8D34-1B7842803354Q37995682-5966574D-43D6-4FD5-A8ED-311C272B59CEQ38132668-441F6817-D643-45F6-BDB8-BBF189275510
P2860
Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1
description
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
im Februar 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/02/11)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/02/11)
@nl
наукова стаття, опублікована в лютому 2003
@uk
مقالة علمية (نشرت في 11-2-2003)
@ar
name
Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1
@ast
Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1
@en
Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1
@nl
type
label
Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1
@ast
Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1
@en
Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1
@nl
prefLabel
Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1
@ast
Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1
@en
Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1
@nl
P2860
P921
P1433
P1476
Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1
@en
P2093
Karen Heyninck
Marja M Kreike
P2860
P304
P356
10.1016/S0014-5793(03)00041-3
P407
P50
P577
2003-02-01T00:00:00Z